Stocky
PHVS
Pharvaris N.V.
NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals · NL
33.42
▼ -1.33%

What's happening at Pharvaris N.V.

Pharvaris N.V.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 5 Aug 2026
Big update 8 May 2026

Pharvaris raises $108 million selling new shares

When companies sell new shares, existing investors own a smaller piece, but the money raised funds growth and operations.

SEC 424B5 · filed 2026-05-08 View filing ↗

Common questions

How does Stocky track Pharvaris N.V.'s company events?

Stocky reads Pharvaris N.V.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Pharvaris N.V.'s most recent SEC filing?

Pharvaris N.V.'s most recent tracked filing was a 424B5 on 8 May 2026: Pharvaris raises $108 million selling new shares.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Pharvaris N.V.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.